Tykerb - Dual Tyrosine Kinase Inhibitor

Specifications - Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours


Key Data
Drug (Brand/Generic)Tykerb/Tyverb/Lapatinib ditosylate
Company/LicenseeGlaxoSmithKline
Therapy ClassTKI
Product DescriptionDual-acting TKI that targets erbB1 and erbB2
Current IndicationBreast cancer
Market SectorOncology
Development StatusApproved US and Europe


client logon
Home
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?